Skip to Content

Cefaclor Suspension

Last Updated: May 15, 2013
Status: Resolved

Products Affected - Description

Cefaclor Suspension

Reason for the Shortage

  • Cefaclor suspension is one of 30 generic products from Ranbaxy that had an FDA import ban.
  • Ranbaxy requested withdrawal of approval for the current cefaclor ANDA in 2012.
  • Pack Pharmaceuticals began marketing cefaclor suspension in 2012.

Available Products

Cefaclor Suspension 125 mg/5 mL, Pack Pharmaceuticals
150 mL bottle (NDC 16571-0070-12)

Cefaclor Suspension 250 mg/ 5 mL, Pack Pharmaceuticals
150 mL bottle (NDC 16571-0071-12)

Cefaclor Suspension 375 mg/ 5 mL, Pack Pharmaceuticals
100 mL bottle (NDC 16571-0072-11)

Estimated Resupply Dates

  • Pack has all presentations available.    

Related Shortages

Updated

May 15, 2013; April 9, 2013; January 30, 2013; January 28, 2013; December 19, 2012; September 19, 2012; May 22, 2012; February 8, 2012; December 7, 2011; September 21, 2011; July 26, 2011; May 17, 2011; March 14, 2011; January 12, 2011; October 25, 2010; August 23, 2010; June 30, 2010; May 10, 2010; March 16, 2010; January 25, 2010; December 9, 2009; October 30, 2009; September 25, 2009; August 20, 2009, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide